دورية أكاديمية
Will Africans take COVID-19 vaccination?
| العنوان: | Will Africans take COVID-19 vaccination? |
|---|---|
| المؤلفون: | Anjorin AA; Department of Microbiology (Virology Research), Lagos State University, Lagos, Nigeria., Odetokun IA; Department of Veterinary Public Health & Preventive Medicine, University of Ilorin, Ilorin, Nigeria., Abioye AI; Harvard University, Boston, Massachusetts, United States of America., Elnadi H; Tours University, Tours, France., Umoren MV; Cincinnati Children's Hospital, Cincinnati, Ohio, United States of America., Damaris BF; Hannover Medical School, Hannover, Germany., Eyedo J; Department of Microbiology (Virology Research), Lagos State University, Lagos, Nigeria., Umar HI; Department of Biochemistry, Federal University of Technology, Akure, Ondo State, Nigeria., Nyandwi JB; Department of Pharmacy, University of Rwanda & Department of Pharmacology, College of Medicine, Gyeongsang National University, Gyeongsang, Republic of Korea., Abdalla MM; Department of Obstetrics and Gynaecology, Minya Health Insurance Hospital, Minya, Egypt., Tijani SO; Department of Medical Microbiology and Parasitology, College of Medicine University of Lagos, Idi Araba, Lagos, Nigeria., Awiagah KS; Accident and Emergency Centre, Korle Bu Teaching Hospital, Accra, Ghana., Idowu GA; Department of Mathematics, Lagos State University, Lagos, Nigeria., Fabrice SNA; Health Research Foundation, Buea, Cameroon., Maisara AMO; Department of Nephrology and Hemodialysis Center, Bahre Teaching Hospital, & Faculty of Medicine, International University of Africa, Khartoum, Sudan., Razouqi Y; Biological Engineering Laboratory, Sultan Moulay Slimane University Beni Mellal, Beni Mellal, Morocco., Mhgoob ZE; Department of Public Health & Infection Control, Aljawda Hospital & El Nileen University Community Development College, Khartoum, Sudan., Parker S; Division of Infectious Disease & HIV Medicine, University of Cape Town, Cape Town, South Africa., Asowata OE; Africa Health Research Institute, University of KwaZulu-Natal, Durban, South Africa., Adesanya IO; US Army Reserve & Hospitalist, BayouCity Physicians, Spring, Texas, United States of America., Obara MA; Hannover Medical School, Hannover, Germany., Jaumdally S; University of Cape Town Lung Institute, Cape Town, South Africa., Kitema GF; Department of Ophthalmology, University of Rwanda, Kigali, Rwanda.; St-Andrews University, St Andrews, United Kingdom., Okuneye TA; Department of Family Medicine, General Hospital Odan, Lagos, Nigeria., Mbanzulu KM; Department of Tropical Medicine, Parasitic and Infectious Diseases, University of Kinshasa, Kinshasa, Democratic Republic of Congo., Daitoni H; HIV and Malaria Research Unit, Malawi and Islamic Health Association of Malawi, Limbe, Malawi., Hallie EF; Department of Pharmacology and Toxicology, School of Pharmacy, University of Liberia, Monrovia, Liberia., Mosbah R; Infection Control Unit, Zagazig University, Zagazig, Egypt.; Faculty of Oral and Dental Medicine, Ahram Canadian University, 6th of October City, Egypt., Fasina FO; Department of Veterinary Tropical Diseases, Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agricultural Organization of the United Nations (FAO), University of Pretoria, Pretoria, South Africa. |
| المصدر: | PloS one [PLoS One] 2021 Dec 01; Vol. 16 (12), pp. e0260575. Date of Electronic Publication: 2021 Dec 01 (Print Publication: 2021). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: San Francisco, CA : Public Library of Science |
| مواضيع طبية MeSH: | Black People/*psychology , COVID-19/*prevention & control , Vaccination/*psychology, Adolescent ; Adult ; Aged ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; Cross-Sectional Studies ; Female ; Health Literacy ; Health Status ; Humans ; Knowledge ; Male ; Middle Aged ; SARS-CoV-2/isolation & purification ; Surveys and Questionnaires ; Young Adult |
| مستخلص: | The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online cross-sectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences. Competing Interests: The authors have declared that no competing interests exist. |
| References: | Nations Natl. 2020 Jul 19;:. (PMID: 32837223) BMC Public Health. 2020 Feb 12;20(1):222. (PMID: 32050948) Nat Med. 2021 Feb;27(2):225-228. (PMID: 33082575) Vaccines (Basel). 2021 Feb 16;9(2):. (PMID: 33669441) Vaccines (Basel). 2021 Feb 19;9(2):. (PMID: 33669659) Clin Exp Immunol. 2020 Nov;202(2):162-192. (PMID: 32935331) Pragmat Obs Res. 2020 Oct 29;11:103-109. (PMID: 33154695) Cell. 2020 Oct 15;183(2):290-295. (PMID: 33064982) PLoS One. 2021 Feb 17;16(2):e0247351. (PMID: 33596272) Am J Trop Med Hyg. 2020 Oct;103(4):1621-1629. (PMID: 32783794) BMJ Glob Health. 2020 May;5(5):. (PMID: 32451367) GeoJournal. 2020 Aug 27;:1-14. (PMID: 32868960) BMJ. 2021 Mar 11;372:n699. (PMID: 33707182) Adv Drug Deliv Rev. 2021 Mar;170:1-25. (PMID: 33359141) PLoS One. 2020 Dec 22;15(12):e0244420. (PMID: 33351852) JAMA. 2020 Jun 23;323(24):2458-2459. (PMID: 32421155) BMJ Glob Health. 2021 Feb;6(2):. (PMID: 33597280) J Infect Dis. 2020 Jul 6;222(3):351-355. (PMID: 32492144) Antibiotics (Basel). 2019 Nov 29;8(4):. (PMID: 31795341) Trop Med Int Health. 2021 Jan;26(1):2-13. (PMID: 33012053) Pers Individ Dif. 2021 Apr;172:110590. (PMID: 33518869) Hum Vaccin Immunother. 2021 Mar 8;:1-3. (PMID: 33684019) J Glob Health. 2020 Dec;10(2):020375. (PMID: 33110566) Glob Health Res Policy. 2021 Jul 29;6(1):26. (PMID: 34325747) Trends Cogn Sci. 2021 May;25(5):331-333. (PMID: 33618982) JAMA. 2013 Nov 27;310(20):2191-4. (PMID: 24141714) Lancet. 2021 Feb 13;397(10274):566. (PMID: 33581810) Glob Public Health. 2020 Oct;15(10):1417-1429. (PMID: 32780635) J Med Virol. 2021 Jul;93(7):4280-4291. (PMID: 33644891) |
| المشرفين على المادة: | 0 (COVID-19 Vaccines) |
| تواريخ الأحداث: | Date Created: 20211201 Date Completed: 20211208 Latest Revision: 20221207 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC8635331 |
| DOI: | 10.1371/journal.pone.0260575 |
| PMID: | 34851998 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0260575 |